BIOFLOW-V: A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions
Event:
ESC Congress 2017
Topic:
PCI / stents: devices and technique
Session:
Late-Breaking Science in PCI 1